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Definition 
Cirrhosis is the final histological pathway for a wide 
variety of liver diseases characterized by fibrosis and 
the conversion of normal liver architecture into 
structurally abnormal nodules that leads to portal 
hypertension, hepatic encephalopathy, and liver 
cancer with very variable progression  from over 
weeks to many years. 
http://patient.info/doctor/cirrhosis-pro 
USMLE TEST 
A 62-year-old white male presents to a primary care doctor with 
concern for weight gain, abdominal distension, and breast enlargement. 
Physical exam reveals an overweight male with bilateral gynecomastia 
and a distended abdomen with evidence of shifting dullness and several 
skin lesions as demonstrated in Image. The patient has a past medical 
history of recurrent gout and Wernicke encephalopathy. Which aspect 
of the patient's history would reveal the most-likely underlying cause of 
the patient's chief complaints?           
1.  Surgical history revealing a blood transfusion in 1984, 2.  Travel 
history revealing time spent 20 years ago in South America, 3.  Review of 
systems revealing constant headaches and nausea that are worse upon 
waking, 4.  Social history revealing alcohol abuse, 5.  Medical history 
revealing arthritis self-treated with large quantities of acetaminophen.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4: This patient's presentation is consistent with 
cirrhosis, for which the most likely cause in this patient is alcohol abuse. 
Incorrect answers: 
1: History of a blood transfusion in 1984 puts a patient at risk for HIV 
and hepatitis C transmission. HIV is not a major cause of cirrhosis. 
Hepatitis C is less likely a cause in this patient with their history of gout 
and Wernicke's encephalopathy - two pathologies that are exacerbated 
by alcohol., 2: Such a travel history may have exposed the patient to 
schistosomiasis (among other possible infections), a parasite that 
resides in the host's liver, but is a rare cause of cirrhosis., 3: Constant 
morning headaches and nausea are concerning for increased 
intracranial pressure. This is not associated with nor a cause of 
cirrhosis., 5: Large doses of acetaminophen can result in acute hepatic 
failure, but are unlikely to cause chronic liver disease leading to 
cirrhosis. 
 https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Epidemiology 1 
• Cirrhosis is the ninth leading cause of death in the 
United States and is responsible for 1.2% of all US 
deaths 
• Many patients die in their fifth or sixth decade of 
life  
• The prevalence is higher in non-Hispanic blacks and 
Mexican Americans, those living below the poverty 
level, and those with less than a 12th grade 
education  
http://emedicine.medscape.com/article/185856-overview#a3 
Epidemiology 2 
• Each year, 2000 additional deaths are attributed 
to fulminant hepatic failure (FHF), that may be 
caused viral hepatitis, drugs (e.g., acetaminophen), 
toxins (e.g., Amanita phalloides, the yellow death-
cap mushroom), autoimmune hepatitis, Wilson 
disease, or a variety of less common etiologies. 
Cryptogenic causes are responsible for one third of 
fulminant cases.   
http://emedicine.medscape.com/article/185856-overview#a3 
Epidemiology 
https://static-content.springer.com/esm/art%3A10.1186%2Fs12916-014-0145-y/MediaObjects/12916_2014_145_MOESM15_ESM.gif 
Liver cirrhosis mortality in 187 countries between 
1980 and 2010: a systematic analysis. 
Risk Factors and Etiology 1 
• Hepatitis C, B, B+D,  
• Alcoholic liver disease  
• Cryptogenic  
• Autoimmune hepatitis 
• Biliary cirrhosis and primary sclerosing cholangitis 
• Hemochromatosis, Wilson disease, alpha-1 
antitrypsin deficiency 
• Granulomatous disease (e.g., sarcoidosis)  
file:///C:/Users/asus/Downloads/JJM_Issue_14,_267-272.pdf 
Risk Factors and Etiology 2 
• Type IV glycogen storage disease 
• Drug-induced liver disease (methotrexate, 
amiodarone, etc.) 
• Venous outflow obstruction (Budd-Chiari syndrome, 
etc.) 
• Congestive heart failure  
• Male sex, age >50, regular (moderate) alcohol 
consumption. 
file:///C:/Users/asus/Downloads/JJM_Issue_14,_267-272.pdf 
Risk Factors and Etiology 
http://www.mdpi.com/1422-0067/15/5/7500/htm 
Non-alcoholic fatty liver disease (NAFLD). 
USMLE TEST 
A 42-year-old female presents with yellowing of the skin. She also 
reports that her urine has been darker than normal and her stools have 
been lighter than normal. Vital signs are stable. Physical examination 
reveals hepatosplenomegaly. Initial labs are notable for increased 
conjugated bilirubin, increased cholesterol, and increased alkaline 
phosphatase. If this patient's symptoms are due to an autoimmune 
reaction leading to lymphocytic infitration of and granulmonatous 
proliferation along the biliary track, which of the following additional 
labs would likely be positive?  
1.  Antimitochondrial antibodies  
2.  Antiendomysial antibodies  
3.  Anti-Jo-1 antibodies  
4.  Antihistone antibodies  
5.  Anticentromere antibodies  
 https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 1: This patient's presentation is consistent with 
primary biliary cirrhosis. Elevated antimitochondrial antibodies may also 
be found in this disease.  
Incorrect answers: 
2: Antiendomysial antibodies are found in Celiac disease. 
3: Anti-Jo-1 antibodies are found in polymyositis and dermatomyositis. 
4: Antihistone antibodies are found in drug-induced lupus. 
5: Anticentromere antibodies are found in scleroderma (CREST) 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Mechanism 1 
• Liver cirrhosis is the final pathological result of 
various chronic liver diseases, and fibrosis is the 
precursor of cirrhosis 
• Many types of cells, cytokines and miRNAs are 
involved in the initiation and progression of liver 
fibrosis and cirrhosis 
• Activation of hepatic stellate cells (HSCs) is a pivotal 
event in fibrosis  hepatocytes contribute to 
pathogenesis of cirrhosis  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064077/ 
Mechanism 2 
• Defenestration and capillarization of liver sinusoidal 
endothelial cells are major contributing factors to 
hepatic dysfunction in liver cirrhosis  
• Activated Kupffer cells destroy hepatocytes and 
stimulate the activation of HSCs 
• Repeated cycles of apoptosis and regeneration of 
hepatocytes contribute to pathogenesis of cirrhosis 
• At the molecular level, many cytokines are involved 
in mediation of signaling pathways that regulate 
activation of HSCs and fibrogenesis  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064077/ 
Mechanism 3 
• Recently, miRNAs as a post-transcriptional regulator 
have been found to play a key role in fibrosis and 
cirrhosis 
• Robust animal models of liver fibrosis and cirrhosis, 
as well as the recently identified critical cellular and 
molecular factors involved in the development of 
liver fibrosis and cirrhosis will facilitate the 
development of more effective therapeutic 
approaches for these conditions. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064077/ 
Mechanism 
http://www.medscape.com/viewarticle/573027 
Formal pathogenesis of liver fibrogenesis. 
Mechanism 
http://www.nature.com/nrc/journal/v6/n9/images/nrc1934-f2.jpg 
Mechanism 
http://perspectives.galectintherapeutics.com/wp-content/uploads/2016/02/Screen-Shot-2016-02-22-at-8.07.39-AM.png 
Portal hypertension. 
Mechanism 
http://images.slideplayer.com/20/6056890/slides/slide_67.jpg 
Portosystemic anastomosis. 
USMLE TEST 
A 47-year-old woman with scleroderma is referred to the emergency 
department by her primary care physician. She had presented to him 
earlier that morning complaining of 2 weeks of fatigue and smelly, fatty 
bowel movements, as well as yellowing of her skin. She also notes 
intermittent abdominal cramping that worsens with meals. Preliminary 
labs reveal a total bilirubin of 4.2 mg/dL, direct 3.8 mg/dL and indirect 
0.4 mg/dL. The alkaline phosphatase is elevated at 280 IU/L. She tells 
you she read about a liver disease that may be related to her 
scleroderma. Which of the following is the best initial method to 
address this woman's concern?   
1.  Serologic tests for presence of autoantibody, 2.  Ultrasonography  
3.  Blood smear, 4.  Computed tomography, 5.  Biopsy.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 2: In this patient with a conjugated 
hyperbilirubinemia and elevated alkaline phosphatase, a right upper 
quadrant ultrasound is the diagnostic modality of choice in 
distinguishing between intra- and extrahepatic biliary obstruction.  
Incorrect answers: 
1: If one has strong suspicion for primary biliary cirrhosis (PBC), several 
antibody tests can be useful. However, one must first determine if there 
is evidence of biliary obstruction and where the obstruction is located, 
using ultrasound, 3: A blood smear can be useful in patients with 
hyperbilirubinemia due to hemolysis, 4: A CT may be helpful in 
diagnosing an obstructive malignancy, but is generally reserved for use 
after the right upper quadrant ultrasound, 5: A biopsy is necessary for 
the diagnosis of PBC. However, one must first determine if there is 
evidence of biliary obstruction on imaging and where the obstruction is 
located. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Classification  
International Classification of Diseases   
https://www.tsoshop.co.uk/productimages/default.aspx?ISBN=9789241549165&FORMAT=3  http://apps.who.int/classifications/icd10/browse/2016/en#/XI 
XI Diseases of the digestive 
K70.3Alcoholic cirrhosis of liver 
K71.7Toxic liver disease with fibrosis and 
cirrhosis of liver 
K74 Fibrosis and cirrhosis of liver 
K74.3Primary biliary cirrhosis 
K74.4Secondary biliary cirrhosis 
K74.5Biliary cirrhosis, unspecified 
K74.6Other and unspecified cirrhosis of liver. 
Classification 
World Health Organization (Anthony P.P. et al. J Clin 
Pathol 31:395,1978)  
 
• Morphologic: macronodular, micronodular, mixed  
• Histologic: portal, post-necrotic, post hepatitis, 
biliary, congestive  
• Etiologic agents: genetic (i.e. biliary atresia, cystic 
fibrosis, Wilson Disease), toxic, infectious, biliary, 
vascular (i.e. congestive heart failure), cryptogenic 
(which the cause is unknown), fatty liver. 
meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm  
Classification 
http://depts.washington.edu/hepstudy/definitions/uploads/18/Child_Pugh_Turcotte.png 
Symptoms 1 
• Decreased appetite  
• Edema  
• Ascites  
• Easy bruising  
• Poor concentration and memory  
• Bleeding esophageal varices  
• Spontaneous bacterial peritonitis 
• Weight loss  
 
https://en.wikipedia.org/wiki/Cirrhosis healthline.com/health/cirrhosis#Symptoms4 patient.info/doctor/cirrhosis-pro 
Symptoms 2 
• Anorexia  
• Weakness 
• Impotence 
• Gynecomastia. 
 
https://en.wikipedia.org/wiki/Cirrhosis healthline.com/health/cirrhosis#Symptoms4 patient.info/doctor/cirrhosis-pro 
USMLE TEST 
A 32-year-old female with a history of scleroderma presents with 6 
months of worsening daytime somnolence, right upper quadrant 
discomfort, and pruritis. Lab tests reveal an elevation of alkaline 
phosphatase and positive anti-mitochondrial antibody. Which of the 
following liver biopsy descriptions confirms the suspected diagnosis? 
1.  Hepatocyte swelling and necrosis with macrovesicular fat, Mallory 
bodies, and neutrophilic infiltration, 2.  Periductal portal tract fibrosis 
and segmental stenosis of extrahepatic and intrahepatic bile ducts  
3.  Centrilobular necrosis, 4.  Non-suppurative destructive cholangitis 
and destruction of inter-lobular bile ducts, 5.  Lobular disarray, 
ballooning degeneration, numerous apoptotic bodies, Kupffer cell 
activation, and lymphocyte-predominant lobular and portal 
inflammation.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4: The patient description is characteristic of 
primary biliary cirrhosis (PBC). Non-suppurative destructive cholangitis 
and progressive loss of intrahepatic bile ducts are the hallmark of PBC. 
Incorrect answers: 
1: This description is characteristic of alcohol-related hepatitis or 
nonalcoholic fatty liver disease. 
2: This description is characteristic of primary sclerosing cholangitis. 
3: This description is characteristic of acute acetominophen toxicity. 
5: This description is characteristic of chronic hepatitis B. 
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Signs                                                       
Cutaneous Features 1 
• Jaundice  
• Scratch marks secondary to pruritus  
• Spider angiomata/naevi (mainly found on the trunk 
and face) 
• Skin telangiectasia's ('paper money skin') 
• Palmar erythema 
• Bruising 
• Petechia or purpura  
http://patient.info/doctor/cirrhosis-pro 
Signs                                                       
Cutaneous Features 2 
• Hair loss 
• White nails (sign of hypoalbuminemia) 
• Finger clubbing 
• Dupuytren's contracture. 
http://patient.info/doctor/cirrhosis-pro 
Signs                                                         
Other Features 
• Hepatomegaly and a nodular liver  
• Edema  
• Gynecomastia and male hair loss pattern  
• Hypogonadism/testicular atrophy/amenorrhoea 
(due to the direct toxic effect of alcohol in alcoholic 
cirrhosis or iron in haemochromatosis) 
• Kayser-Fleischer ring (a brown-green ring of copper 
deposit around the cornea, pathognomonic for 
Wilson's disease). 
http://patient.info/doctor/cirrhosis-pro 
Signs                                                     
Portal Hypertension 1   
• Hepatic venous pressure gradient (HVPG) greater 
than or equal to 5mm Hg and is considered to be 
clinically significant when HVPG exceeds 10 to 12 
mm Hg 
• The main symptoms and complications:  
• ascites (an accumulation of fluid in the abdomen, 
can be detected clinically when ≥1.5 litres of fluid 
is present); dilated veins in the anterior 
abdominal wall (caput medusae, when veins seen 
radiating from the umbilicus) 
webmd.com/digestive-disorders/digestive-diseases-portalen.wikipedia.org/wiki/Portal_hypertension patient.info/doctor/cirrhosis-pro 
Signs                                                     
Portal Hypertension 2   
• encephalopathy or confusion and forgetfulness 
caused by poor liver function;   
• splenomegaly;  
• reduced levels of platelets or white blood cells;  
• gastrointestinal bleeding marked by black, tarry 
stools or blood in the stools, or vomiting of blood 
due to the spontaneous rupture and hemorrhage 
from varices. 
webmd.com/digestive-disorders/digestive-diseases-portalen.wikipedia.org/wiki/Portal_hypertension patient.info/doctor/cirrhosis-pro 
Signs                                                   
Hepatic Encephalopathy 
• Asterixis ('flapping tremor'); suggests hepatic 
encephalopathy 
• To detect asterixis, take the patient's hand and 
gently hyperextend the wrist and joints of the hand, 
pushing gently on the tips of the four fingers 
• Ignore the thumb 
• Hold that position for several seconds and you will 
feel a slow, clonic flexion-relaxation movement 
against your hand if asterixis is present. 
http://patient.info/doctor/cirrhosis-pro 
Clinical Presentation 
• Up to 40% of people with cirrhosis may be 
asymptomatic 
• Blood testing for other reasons may reveal 
abnormal liver function and prompt further 
investigation which shows cirrhosis  
• Initial clinical presentation of patients with 
decompensated cirrhosis is still common and is 
characterized by the presence of dramatic and life-
threatening complications, such as variceal 
hemorrhage, ascites, spontaneous bacterial 
peritonitis, or hepatic encephalopathy. 
 ncbi.nlm.nih.gov/pmc/articles/PMC2271178/  patient.info/doctor/cirrhosis-pro 
Clinical Presentation                          
Activity Grades   
• Inactive: no inflammation and intact limiting plates 
around septa which are fibrotic 
• Slight: mild inflammation; segmental erosion of 
limiting plates 
• Moderate: moderate inflammation and damage of 
limiting plates 
• Severe: marked inflammation, extensive damage of 
limiting plates, piecemeal necrosis and parenchymal 
damage (necrosis, cholestasis, dysplasia, malignant 
transformation. 
meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm   ncbi.nlm.nih.gov/pmc/articles/PMC2271178/  patient.info/doctor/cirrhosis-pro 
Clinical Presentation                                                  
Decompensation   
• In patients with previously stable cirrhosis, 
decompensation may occur due to various causes, 
such as constipation, infection (of any source), 
increased alcohol intake, medication, bleeding from 
esophageal varices or dehydration 
• Patients with decompensated cirrhosis generally 
require admission to hospital, with close monitoring 
of the fluid balance, mental status, and emphasis on 
adequate nutrition and medical treatment.    
en.wikipedia.org/wiki/Cirrhosis  
Complications 
http://patient.info/doctor/cirrhosis-pro 
• Anemia, thrombocytopenia and coagulopathy 
(folate deficiency, 
hemolysis, hypersplenism, cholestasis)  
• Esophageal varices (portal hypertension) 
• Ascites 
• Spontaneous bacterial peritonitis   
• Hepatocellular carcinoma     
• Cirrhotic cardiomyopathy   
• Hepatopulmonary syndrome   
• Portopulmonary hypertension. 
USMLE TEST 
A 46-year-old woman presents to her primary care provider for itching. 
She has dry skin but. The patient endorses fatigue and dull abdominal 
pain. Her past medical history includes Hashimoto’s thyroiditis and 
osteoarthritis. She takes levothyroxine and ibuprofen for pain in her 
knees. The patient drinks 2-3 beers per week. On physical exam, her 
sclera are anicteric. Her abdomen is soft and tender to palpation in the 
right upper quadrant. Hepatomegaly is present. A right upper quadrant 
ultrasound shows no evidence of extrahepatic biliary dilation. 
Laboratory studies are performed which reveal the following: Aspartate 
aminotransferase: 76 U/L, Alanine aminotransferase: 57 U/L, Alkaline 
phosphatase: 574 U/L, Total bilirubin: 1.6 mg/dL. This patient is most 
likely to have which of the following additional findings?   
1.  Hyperlipidemia, 2.  Skin hyperpigmentation, 3.  Anti-smooth muscle 
antibodies, 4.  Anti-neutrophil cytoplasmic antibodies, 5.  Personality 
changes.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 1: This patient presents with fatigue, pruritus, 
cholestatic pattern of liver injury, and a right upper quadrant (RUQ) 
ultrasound without extrahepatic biliary dilation, which is consistent with 
a diagnosis of primary biliary cirrhosis (PBC).   
Incorrect answers: 
 2: Skin hyperpigmentation is characteristic of hereditary 
hemochromatosis (HH), 3: Anti-smooth muscle antibodies would 
suggest a diagnosis of autoimmune hepatitis. Autoimmune hepatitis 
would present with elevated liver enzymes, 4: Anti-neutrophil 
cytoplasmic antibodies are associated with primary sclerosing 
cholangitis (PSC), as seen in Illustration, 5: Personality changes and 
other neuropsychiatric symptoms may be clinical manifestations of 
Wilson’s disease. Patients with Wilson’s disease are likely to have an 
elevated AST/ALT with a normal alkaline phosphatase. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Diagnosis 1 
• The gold standard for diagnosis of cirrhosis is a liver 
biopsy, through a percutaneous, transjugular, 
laparoscopic, or fine-needle approach 
• A biopsy is not necessary if the clinical, laboratory, 
and radiologic data suggests cirrhosis  
https://en.wikipedia.org/wiki/Cirrhosis#Pathophysiology 
Diagnosis 2 
• Furthermore, there is a small but significant risk to 
liver biopsy, and cirrhosis itself predisposes for 
complications caused by liver biopsy 
• The best predictors of cirrhosis are ascites, platelet 
count <160,000/mm3, spider angiomata, and 
Bonacini cirrhosis discriminant score greater than 7. 
https://en.wikipedia.org/wiki/Cirrhosis#Pathophysiology 
Diagnosis                                             
Laboratory Testing  1   
emedicine.medscape.com/article/182098-overview  
• Complete blood count and liver disease–associated 
blood tests (e.g., aspartate aminotransferase [AST], 
alanine aminotransferase [ALT], bilirubin, alkaline 
phosphatase [ALP]) 
• Coagulation tests (prothrombin time [PT], partial 
thromboplastin time [PTT], international 
normalized ratio [INR]) 
• Albumin: hypoalbuminemia (impaired hepatic 
synthetic function)  
Diagnosis                                             
Laboratory Testing  2  
emedicine.medscape.com/article/182098-overview  
• Blood urea nitrogen, creatinine, and electrolytes 
• Arterial blood gas (ABG) and pH measurements 
• Hepatic and viral hepatitis serologies, antinuclear 
antibody, antimitochondrial antibody, antismooth 
muscle antibody 
• Iron indices, alpha1-antitrypsin deficiency, 
ceruloplasmin, 24-hour urinary copper. 
Diagnosis                                             
Imaging Studies   
intechopen.com/source/html/18256/media/image35.jpg emedicine.medscape.com/article/182098-overview 
• Duplex Doppler ultrasonography of the liver and 
upper abdomen 
• Computed tomography (CT) scanning and/or 
magnetic resonance imaging (MRI): can be used 
when ultrasonographic findings are inconclusive 
• Bleeding scan or angiography: Used when bleeding 
is obscure and the source is uncleuar. 
Diagnosis                                            
Procedures 1 
 emedicine.medscape.com/article/182098-overview  
•  Liver biopsy and histologic 
examination 
• Hemodynamic measurement 
of the hepatic venous pressure 
gradient (HVPG): A criterion 
standard for assessment of 
portal hypertension  
Diagnosis                                            
Procedures 2 
 emedicine.medscape.com/article/182098-overview  
• Upper GI endoscopy (or, 
esophagogastroduodenoscopy 
[EGD]): A criterion standard for 
assessment of portal 
hypertension.   
Diagnosis                                             
Histopathologic Features    
https://www.pathology.med.umich.edu/greensonlab/severechronhep.jpg 
Diagnosis                                             
Morphological Type    
https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Cirrhosis_high_mag.jpg/440px-Cirrhosis_high_mag.jpg  
meddean.luc.edu/lumen/meded/orfpath/images/fig78x.jpgpathology.med.umich.edu/greensonlab/severechronhep.jpg 
• Micronodular < 3 mm 
• Macronodular > 3 mm 
• Mixed 
Diagnosis                                               
West Haven Criteria Grading System of Hepatic 
Encephalopathy   
aafp.org/afp/2011/1215/p1353.html  
Grade Description 
1 
Trivial lack of awareness; euphoria or anxiety; 
shortened attention span; impaired performance of 
addition or subtraction 
2 
Lethargy or apathy; minimal disorientation for time or 
place; subtle personality change; inappropriate 
behavior 
3 
Somnolence to semistupor, but responsive to verbal 
stimuli; confusion; gross disorientation 
4 Coma (unresponsive to verbal or noxious stimuli) 
USMLE TEST 
Mrs. Jones is a 56-year-old female that is admitted to a general 
medicine floor of the local university hospital. She is noted to have new 
onset ascites of unknown origin. Peritoneal fluid was sent for cell count 
(<50 leukocytes), albumin level (4.8), culture (pending), total protein 
(2.0), and Gram stain (pending). Serum albumin was noted to be 4.0. Of 
the options below, what is the most likely cause of this patient's 
ascites?   
 
1.  Congestive heart failure  
2.  Alcoholic hepatitis  
3.  Cirrhosis  
4.  Pancreatitis  
5.  Vascular occlusion  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4: The patient in the above vignette has a serum 
albumin ascites gradient (SAAG) of -0.8 g/dL which puts it into the 
category of non-portal hypertensive ascites. Pancreatitis is the only 
cause of non-portal hypertensive ascites listed above. 
Incorrect answers: 
1-3,5: All of these forms of pathology represent a portal hypertensive 
cause of ascites and would have a SAAG >1.1 g/dL. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Management 1 
• A healthy diet is encouraged, as cirrhosis may be an 
energy-consuming process 
• Antibiotics are prescribed for infections, and various 
medications can help with itching 
• Laxatives, such as lactulose, decrease risk of 
constipation 
• Alcoholic cirrhosis is treated by abstaining from 
alcohol  
https://en.wikipedia.org/wiki/Cirrhosis 
Management 2 
• Treatment for hepatitis-related cirrhosis involves 
medications used to treat the different types of 
hepatitis 
• Cirrhosis caused by Wilson's disease is treated 
with chelation therapy (penicillamine) to remove 
the copper 
• Vaccination of susceptible patients should be 
considered for Hepatitis A and Hepatitis B. 
https://en.wikipedia.org/wiki/Cirrhosis 
Management                                             
Nutrition 1 
• Malnutrition occurs up to 60% of patients, and 
guidelines recommend a daily protein intake of 1.0 
to 1.5 g per kilogram of dry body weight 
• High-protein diets are well tolerated and are 
associated with sustained improvement in mental 
status, whereas restriction of protein intake does 
not have any beneficial effect in patients with acute 
hepatic encephalopathy   
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                             
Nutrition 2 
• Late-evening meals may improve nitrogen balance 
without exacerbating hepatic encephalopathy 
• A 2000-mg limit in daily sodium intake is mandatory 
in the treatment of ascites 
• Fluid restriction recommend only when the serum 
sodium concentration is less than 120 mmol per 
liter.   
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                   
Medications: Antihypertensive and Hypertensive Agents 1 
• Nonselective beta-blockers reduce portal pressures 
and are used in the primary and secondary 
prophylaxis of variceal hemorrhage    
• Antihypertensive agents should be discontinued in 
patients who have decompensated cirrhosis with 
ascites or hypotension  
• In patients with stable hypotension, midodrine may 
improve splanchnic and systemic hemodynamic 
variables, renal function, and sodium excretion  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                   
Medications: Antihypertensive and Hypertensive Agents 2 
• The combination of octreotide and midodrine is 
used for the treatment of type 1 hepatorenal 
syndrome; type 1 hepatorenal syndrome is defined 
as at least a twofold increase in serum creatinine 
(reflecting a 50 percent reduction in creatinine 
clearance) to a level greater than 
2.5 mg/dL (221 micromol/L) during a period of less 
than two weeks. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                   
Medications: Pain Management 1 
• Because of the risk of acute renal failure and 
gastrointestinal bleeding, nonsteroidal 
antiinflammatory drugs are contraindicated, except 
for low-dose aspirin in patients in whom the 
severity of cardiovascular disease exceeds the 
severity of cirrhosis  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                   
Medications: Pain Management 2 
• Opiates should be used cautiously or avoided, 
because they may precipitate or aggravate hepatic 
encephalopathy  
• Acetaminophen is effective and safe in patients with 
liver disease, provided that the patient does not 
drink alcohol.  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Management                                   
Medications: Proton-Pump Inhibitors 1 
• Proton-pump inhibitors are vastly overprescribed in 
hospitalized patients with cirrhosis, often without 
any documented indication 
• A large study involving patients with cirrhosis who 
were hospitalized with an initial infection showed 
that the risk of subsequent infection was increased 
among patients taking proton-pump inhibitors and 
those receiving long-term antibiotic agents as 
prophylaxis for spontaneous bacterial peritonitis 
• Indiscriminate use without appropriate indications 
should be avoided. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Medications: Sedatives 
• Benzodiazepines should be avoided in patients with 
hepatic encephalopathy 
• For patients with alcoholic hepatitis or cirrhosis in 
whom severe symptoms of acute alcohol 
withdrawal develop, short-acting benzodiazepines 
such as lorazepam and oxazepam are preferred in 
order to minimize the risk of oversedation 
• For patients with insomnia, hydroxyzine at a dose of 
25 mg at bedtime may be a reasonable alternative 
and has been studied in a small, randomized trial.  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Medications: Statins 1 
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase 
inhibitors (statins) can be safely started and 
continued in patients with cirrhosis 
• Statins have established cardiovascular benefits in 
the treatment of nonalcoholic fatty liver disease 
• The overall rate of statin-induced acute liver failure 
is 0.2 to 1 cases per million persons taking statins, 
although estimates of patients who do not receive 
statins because of concerns about hepatotoxicity 
range from 10 to 30%  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Medications: Statins 2 
• Data from the Drug-Induced Liver Injury Network 
corroborated the exceedingly low likelihood of 
hepatic injury due to statins, with only 22 cases of 
drug-induced liver injury being attributed to statins 
over an 8-year period. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Medications: Vaptans 1 
• Selective vasopressin V2–receptor antagonists 
(vaptans) have been evaluated for use in 
hyponatremia and ascites 
• A large, placebo-controlled study involving patients 
with cirrhosis and ascites showed that although 
satavaptan alleviated hyponatremia, mortality was 
higher among patients with recurrent ascites who 
were receiving satavaptan than among those who 
were receiving placebo  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Medications: Vaptans 2 
• Because of these findings as well as hepatotoxicity 
reported with respect to tolvaptan, the use of 
vaptans in patients with cirrhosis and ascites is not 
recommended. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
USMLE TEST 
A 55-year-old former longtime alcoholic presents to clinic complaining 
of new onset increasing abdominal girth and no other complaints. He 
had been a Child's Class A cirrhotic for some time. His wife, who has 
accompanied him on this visit, reports that his mental status is 
unchanged and that he is eating well and attending his Alcoholics 
Anonymous meetings. On physical exam, his vital signs are stable. His 
abdomen is distended and tense without appreciable hepatomegaly. 
There is a fluid wave and shifting dullness. You conduct abdominal 
paracentesis in the office and aspirate 3L of clear fluid. If sodium and 
water restriction fails to control this patient's symptoms, what would be 
the next step in management?   
1.  Add nadolol, 2.  Add hydrochlorothiazide, 3.  Add spironolactone  
4.  Add acetazolamide, 5.  Create a transjugular intrahepatic 
portosystemic shunt.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3: Management of ascites involves sodium and 
water restriction followed by spironolactone, loop diuretics, and 
frequent abdominal paracentesis. 
Incorrect answers: 
1: Nadolol may be used in prophylaxis of esophageal varacies but would 
not be indicated in the control of this patient's ascites, 2: 
Hydrocholorothiazide is a first line agent for essential hypertension but 
is not used for ascites, 4: Acetazolamide is a carbonic anhydrase 
inhibitor which may be used for hypertension but is not indicated for 
ascites, 5: TIPS can be used as a bridge to liver transplant but would not 
be indicated in a patient with Child's class A or B cirrhosis who had not 
already tried medical management of his ascites. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
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Paracentesis 
• Paracentesis is particularly helpful in all patients 
with new-onset ascites, in patients with existing 
ascites who are admitted to the hospital, and in 
patients with clinical deterioration (fever, 
abdominal pain, hepatic encephalopathy, 
leukocytosis, renal failure, or metabolic acidosis) 
• Spontaneous bacterial peritonitis is diagnosed 
when the neutrophil count in ascitic fluid is at least 
250 cells per cubic millimeter and secondary 
bacterial peritonitis is ruled out. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Transplantation 1 
• If complications cannot be controlled or when the 
liver ceases functioning, liver transplantation is 
necessary 
• Survival from liver transplantation has been 
improving over the 1990s, and the five-year survival 
rate is now around 80%  
https://en.wikipedia.org/wiki/Cirrhosis 
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Transplantation 2 
• The survival rate depends largely on the severity of 
disease and other medical problems in the recipient 
• In the United States, the MELD score is used to 
prioritize patients for transplantation 
• Transplantation necessitates the use of immune 
suppressants (ciclosporin or tacrolimus). 
https://en.wikipedia.org/wiki/Cirrhosis 
USMLE TEST 
A 40-year-old man presents to the emergency department with altered 
mental status. He has a history of cirrhosis of the liver secondary to 
alcoholism. Laboratory studies show Na 140, K 2.9, Cl 100, HCO3 36, 
BUN 27, Cr 1.0. His home medications are lactulose and furosemide. 
Physical exam reveals shifting dullness consistent with ascites. Which of 
the following is the most appropriate treatment for this patient?   
 
1.  Dextrose  
2.  Potassium  
3.  Lactulose  
4.  Neomycin  
5.  Hydrochlorothiazide  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 2: This patient is suffering from hepatic 
encephalopathy secondary to hypokalemia and should be treated with 
potassium. 
Incorrect answers: 
1: Dextrose is indicated for the treatment of hypoglycemia. 
 3: Lactulose is used to treat hepatic encephalopathy, but the underlying 
hypokalemia must be corrected first. 
4: Neomycin, an aminoglycoside antibiotic, is used to treat hepatic 
encephalopathy. It kills bowel flora to reduce the production of 
ammonia. However, the patient's underlying hypokalemia must be 
treated first. 
5: Hydrochlorothiazide (HCTZ) would worsen the patient's hypokalemia 
and is not indicated.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
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Decompensated Cirrhosis 1 
• In patients with previously stable cirrhosis, 
decompensation may occur due to various causes, 
such as constipation, infection (of any source), 
increased alcohol intake, medication, bleeding from 
esophageal varices or dehydration   
https://en.wikipedia.org/wiki/Cirrhosis 
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Decompensated Cirrhosis 2 
• Patients with decompensated cirrhosis generally 
require admission to hospital, with close monitoring 
of the fluid balance, mental status, and emphasis on 
adequate nutrition and medical treatment - often 
with diuretics, antibiotics, laxatives and/or enemas, 
thiamine and occasionally steroids, acetylcysteine 
and pentoxifylline 
• Administration of saline is avoided as it would add 
to the already high total body sodium content that 
typically occurs in cirrhosis. 
https://en.wikipedia.org/wiki/Cirrhosis 
USMLE TEST 
A 45-year-old man with hypertension, hyperlipidemia, depression, and 
alcohol abuse presents to the emergency room complaining of right 
lower quadrant pain that started 12 hours prior. Since that time he has 
been unable to hold down any food or liquids. A CT scan is obtained and 
the report indicates acute appendicitis and early stage liver damage. AST 
217, ALT 91. An uneventful laparoscopic appendectomy is performed. 
Upon discharge, the patient is referred to a gastroenterologist to discuss 
the prognosis of his liver disease. Which of the following outcomes is 
most likely discussed with the patient?      
1.  Liver disease is acute and will spontaneously resolve without 
intervention, 2.  Liver disease is reversible if appropriate lifestyle 
changes are enacted, 3.  Liver disease is reversible if appropriate 
medication is administered, 4.  Liver disease is irreversible but 
progression can be slowed with interferon therapy, 5.  Liver disease will 
continue to progress until man receives a liver transplant.  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 2: The gentleman in the question stem has been 
incidentally found to have alcoholic steatosis (i.e. fatty liver disease), 
which is a reversible condition that has the potential to completely 
resolve with alcohol cessation.  
Incorrect answers: 
1: Fatty liver disease will not resolve without alcohol cessation. 
3: The administration of medication will not resolve alcoholic fatty liver 
disease. Alcohol cessation is required to stop further progression of this 
disease. 
4-5: Alcoholic fatty liver disease is a reversible condition if caught in 
early stages, as in this case. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
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Palliative Care 1 
• Palliative care focuses on providing patients with 
relief from the symptoms, pain, and stress of a 
serious illness 
• The goal of palliative care is to improve quality of 
life for both the patient and the patient's family and 
it is appropriate at any stage and for any type of 
cirrhosis  
https://en.wikipedia.org/wiki/Cirrhosis 
Management                                   
Palliative Care 2 
• Because the disease is not curable without a 
transplant, palliative care can also help with 
discussions regarding the person's wishes 
concerning health care power of attorney, Do Not 
Resuscitate decisions and life support, and 
potentially hospice  
• Despite proven benefit, people with cirrhosis are 
rarely referred to palliative care. 
https://en.wikipedia.org/wiki/Cirrhosis 
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Care Coordination 1 
• Patients with cirrhosis are plagued by frequent 
hospital readmissions for fluid overload, hepatic 
encephalopathy, or gastrointestinal hemorrhage 
• Such readmissions are costly, moderately 
predictable, frequently preventable, and associated 
with a risk of death 
• Care coordination is an increasingly popular 
concept to improve quality and clinical outcomes 
while reducing readmission rates and expenditures  
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
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Care Coordination 2 
• Care coordinators facilitate inpatient-to-clinic 
transitions, reconcile medications, call patients to 
prevent unnecessary visits to the emergency 
department, place “smart scales” in homes to 
monitor body weight remotely, facilitate interaction 
with other health care professionals, and arrange 
referrals to nursing facilities or hospice. 
http://www.nejm.org/doi/full/10.1056/NEJMra1504367 
Prognosis 
 
• Prognosis depends on the underlying cause and on 
the success of its treatment 
• If someone with alcoholic cirrhosis continues to 
drink alcohol, the rate of decompensation can be 
rapid 
• Patients with fulminant hepatic failure have a 50-
80% mortality rate unless they receive a liver 
transplant. 
http://patient.info/doctor/cirrhosis-pro 
Prophylaxis 1 
• Worldwide, the most important factor in prevention 
of cirrhosis is immunisation against hepatitis B  
• There is no vaccine against hepatitis C but some 
treatments may delay progression and alcohol must 
be avoided  
• Sensible drinking is essential for everyone and 
patients should be advised about the 
recommended limits   
http://patient.info/doctor/cirrhosis-pro 
Prophylaxis 2 
• Beware of hepatotoxic medications, including 
herbal remedies  
• Weight reduction and exercise can improve liver 
function in patients with NAFLD. 
http://patient.info/doctor/cirrhosis-pro 
Abbreviations  
ALT - alanine aminotransferase  
ALP - alkaline phosphatase  
AST - aspartate aminotransferase  
CH - Cirrhosis of the Liver 
HSCs - hepatic stellate cells  
HVPG - hepatic venous pressure gradient  
EGD - esophagogastroduodenoscopy  
FHF - fulminant hepatic failure  
INR - international normalized ratio  
NAFLD - non-alcoholic fatty liver disease 
miRNA - a small non-coding RNA molecule 
PT - prothrombin time  
PTT - partial thromboplastin time  
Diagnostic and treatment guidelines 
Cirrhosis: Diagnosis, Management, and Prevention 
NICE Guideline on Cirrhosis (2016) 
Guidelines on the management of ascites in cirrhosis 
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